Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Inorg Biochem ; 223: 111546, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1313251

ABSTRACT

Recent studies have shown a correlation between COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and the distinct, exaggerated immune response titled "cytokine storm". This immune response leads to excessive production and accumulation of reactive oxygen species (ROS) that cause clinical signs characteristic of COVID-19 such as decreased oxygen saturation, alteration of hemoglobin properties, decreased nitric oxide (NO) bioavailability, vasoconstriction, elevated cytokines, cardiac and/or renal injury, enhanced D-dimer, leukocytosis, and an increased neutrophil to lymphocyte ratio. Particularly, neutrophil myeloperoxidase (MPO) is thought to be especially abundant and, as a result, contributes substantially to oxidative stress and the pathophysiology of COVID-19. Conversely, melatonin, a potent MPO inhibitor, has been noted for its anti-inflammatory, anti-oxidative, anti-apoptotic, and neuroprotective actions. Melatonin has been proposed as a safe therapeutic agent for COVID-19 recently, having been given with a US Food and Drug Administration emergency authorized cocktail, REGEN-COV2, for management of COVID-19 progression. This review distinctly highlights both how the destructive interactions of HOCl with tetrapyrrole rings may contribute to oxygen deficiency and hypoxia, vitamin B12 deficiency, NO deficiency, increased oxidative stress, and sleep disturbance, as well as how melatonin acts to prevent these events, thereby improving COVID-19 prognosis.


Subject(s)
Antioxidants/pharmacology , COVID-19 Drug Treatment , Melatonin/pharmacology , Reactive Oxygen Species/metabolism , Anti-Inflammatory Agents/pharmacology , Apoptosis/drug effects , COVID-19/immunology , COVID-19/metabolism , Cytokine Release Syndrome/immunology , Cytokines/metabolism , Hemeproteins/metabolism , Humans , Hypochlorous Acid/metabolism , Nitric Oxide/metabolism , Oxidation-Reduction , Oxidative Stress/drug effects , Peroxidase/metabolism , SARS-CoV-2 , Sleep/drug effects , Vitamin B Deficiency/metabolism
2.
Reprod Sci ; 29(1): 1-6, 2022 01.
Article in English | MEDLINE | ID: covidwho-1014274

ABSTRACT

COVID-19 (coronavirus disease 2019) is the current world health crisis, producing extensive morbidity and mortality across all age groups. Given the established roles of zinc in combating oxidative damage and viral infections, zinc is being trialed as a treatment modality against COVID-19. Zinc also has confirmed roles in both male and female reproduction. The possible depletion of zinc with the oxidative events of COVID-19 is especially relevant to the fertility of affected couples. This review aims to present the pathophysiology of COVID-19, especially in relation to reproductive function; the role of zinc in the COVID-19 disease process; and how zinc depletion in concert with cytokine storm and reactive oxygen species production could affect reproduction. It also highlights research areas to better the understanding of COVID-19 and its impact on fertility and potential ways to mitigate the impact.


Subject(s)
COVID-19/metabolism , Oxidative Stress/physiology , Reproduction/physiology , Zinc/metabolism , Female , Humans , Male , Reactive Oxygen Species/metabolism
3.
Int J Biol Sci ; 17(1): 62-72, 2021.
Article in English | MEDLINE | ID: covidwho-948161

ABSTRACT

Multi-system involvement and rapid clinical deterioration are hallmarks of coronavirus disease 2019 (COVID-19) related mortality. The unique clinical phenomena in severe COVID-19 can be perplexing, and they include disproportionately severe hypoxemia relative to lung alveolar-parenchymal pathology and rapid clinical deterioration, with poor response to O2 supplementation, despite preserved lung mechanics. Factors such as microvascular injury, thromboembolism, pulmonary hypertension, and alteration in hemoglobin structure and function could play important roles. Overwhelming immune response associated with "cytokine storms" could activate reactive oxygen species (ROS), which may result in consumption of nitric oxide (NO), a critical vasodilation regulator. In other inflammatory infections, activated neutrophils are known to release myeloperoxidase (MPO) in a natural immune response, which contributes to production of hypochlorous acid (HOCl). However, during overwhelming inflammation, HOCl competes with O2 at heme binding sites, decreasing O2 saturation. Moreover, HOCl contributes to several oxidative reactions, including hemoglobin-heme iron oxidation, heme destruction, and subsequent release of free iron, which mediates toxic tissue injury through additional generation of ROS and NO consumption. Connecting these reactions in a multi-hit model can explain generalized tissue damage, vasoconstriction, severe hypoxia, and precipitous clinical deterioration in critically ill COVID-19 patients. Understanding these mechanisms is critical to develop therapeutic strategies to combat COVID-19.


Subject(s)
COVID-19/physiopathology , Clinical Deterioration , Peroxidase/metabolism , Reactive Oxygen Species/metabolism , COVID-19/metabolism , COVID-19/virology , Catalysis , Humans , Hypochlorous Acid/metabolism , Oxidation-Reduction , SARS-CoV-2/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL